Bio-Rad Laboratories Inc (BIO):医療機器:M&Aディール及び事業提携情報

◆英語タイトル:Bio-Rad Laboratories Inc (BIO) - Medical Equipment - Deals and Alliances Profile
◆商品コード:DATA904C7389
◆発行会社(調査会社):GlobalData
◆発行日:2018年10月
◆ページ数:62
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:医療機器
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Bio-Rad Laboratories Inc (Bio-Rad) develops, manufactures and markets a range of products and systems for the life science research, healthcare, analytical chemistry and other markets. The company’s major products include reagents, apparatus, laboratory instruments, test systems, informatics systems, test kits and specialized quality controls. Bio-Rad offers its products to universities and medical schools, industrial research organizations, pharmaceutical manufacturers, government agencies, biotechnology researchers, food producers, food testing laboratories, reference laboratories, hospital and transfusion laboratories, and physician office laboratories. The company offers its products through direct sales force and also through a network of distributors, agents, brokers and resellers across the world. The company operates in the US, Canada, Latin America, Europe and Pacific Rim, among others. Bio-Rad is headquartered in California, the US.

Bio-Rad Laboratories Inc (BIO) – Medical Equipment – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Medical eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 5
List of Figures 5
Bio-Rad Laboratories Inc, Medical Equipment, Deals By Year, 2012 to YTD 2018 6
Bio-Rad Laboratories Inc, Medical Equipment Deals By Type, 2012 to YTD 2018 7
Bio-Rad Laboratories Inc, Medical Equipment, Deals By Region, 2012 to YTD 2018 8
Bio-Rad Laboratories Inc, Medical Equipment, Deals By Market, 2012 to YTD 2018 9
Bio-Rad Laboratories Inc, Medical Equipment, Deals Summary, 2012 to YTD 2018 10
Bio-Rad Laboratories Inc, Medical Equipment, Deal Details 12
Asset Purchase 12
Bio-Rad Labs Acquires Flow Cytometer from Propel Labs 12
Bio-Rad Labs Acquires Cell Sorting System From Propel Labs 13
Venture Financing 14
Oxford Impedance Diagnostics Raises USD2.6 Million in Seed Financing 14
RainDance Technologies Raises US$16.5 Million In Extended Series E Financing 15
RainDance Technologies Raises US$35 Million In Venture Financing 17
RainDance Technologies Raises US$20 Million In Series E Financing 18
Partnerships 20
AbD Serotec Enters Into Licensing Agreement With DiaSorin For HuCAL Antibodies 20
Bio-Rad Laboratories Enters into Partnership with Illumina 21
RainDance Technologies Enters into Research Agreement with Blood Systems Research Institute 22
Bio-Rad Labs Extends Agreement with Beckman Coulter Diagnostics 23
Bio-Rad Labs Enters Into Co-Development Agreement With Inpeco 24
Bio-Rad Labs Enters Into Co-Marketing Agreement With Lamprogen For Fluorescent Particles 25
RainDance Technologies Enters Into Co-Development Agreement With Integrated DNA Technologies For Digital PCR 26
Bio-Rad Labs Enters Into Distribution Agreement With Myriad RBM For Multiplex Biomarker Kits 27
Bio-Rad Labs Extends Distribution Agreement With Luminex For MAGPIX 28
GnuBIO Enters Into Co-Development Agreement With Montreal Heart Institute 29
Bio-Rad Labs Enters into Licensing agreement with Globavir Biosciences 30
Equity Offering 31
RainDance Withdraws IPO for USD60 Million 31
Acquisition 32
Bio-Rad Labs Acquires RainDance Technologies 32
Bio-Rad Labs Completes Acquisition Of AbD Serotec From MorphoSys 33
Bio-Rad Laboratories Inc – Key Competitors 34
Bio-Rad Laboratories Inc – Key Employees 35
Bio-Rad Laboratories Inc – Locations And Subsidiaries 36
Head Office 36
Other Locations & Subsidiaries 36
Recent Developments 39
Financial Announcements 39
Aug 07, 2018: Bio-Rad reports second-quarter 2018 financial results 39
May 08, 2018: Bio-Rad Announces First Quarter 2018 Financial Results 41
Feb 27, 2018: Bio-Rad Reports Fourth-Quarter and Full-Year 2017 Financial Results 42
Nov 02, 2017: Bio-Rad Reports Third-Quarter 2017 Financial Results 44
Aug 03, 2017: Bio-Rad Reports Second-Quarter 2017 Financial Results 45
May 04, 2017: Bio-Rad Reports First-Quarter 2017 Financial Results 46
Mar 13, 2017: Bio-Rad Initiates Long Term Financial Guidance; Commits to Defining Long Term Capital Allocation Targets and Hosting an Annual Investor Day 47
Feb 23, 2017: VBio-Rad Reports Fourth-Quarter and Full-Year 2016 Financial Results 48
Feb 23, 2017: Bio-Rad Reports Fourth-Quarter and Full-Year 2016 Financial Results 50
Corporate Communications 52
Mar 13, 2017: Bio-Rad Intends to Propose Three New Independent Directors 52
Product News 53
May 24, 2018: Bio-Rad Launches a Range of Anti-idiotypic Antibodies Targeting Pembrolizumab and Nivolumab 53
Mar 08, 2018: Bio-Rad Launches IncRNA Workflow, a RT-qPCR Workflow Optimized for Long Noncoding RNA Discovery and Validation 54
Jan 22, 2018: Bio-Rad Gains Additional U.S. FDA Clearances for Blood Typing Products, Expanding its Offering for the Blood Testing Market 55
Jun 08, 2017: Bio-Rad Launches CFX Maestro Software for Real-Time PCR Data Analysis 56
Apr 03, 2017: 2017 AACR Annual Meeting Presentations Highlight the Use of Bio-Rad’s Droplet Digital PCR Technology for Liquid Biopsies in Cancer Research 57
Jan 23, 2017: Liquid biopsy researchers to share their strategies for pairing digital PCR and next-generation sequencing at Precision Medicine World Conference 59
Jan 09, 2017: Illumina and Bio-Rad Launch Solution for Single-Cell Genomic Sequencing to Enable Robust Study of Complex Diseases 61
Appendix 62
Methodology 62
About GlobalData 62
Contact Us 62
Disclaimer 62

List of Tables
Bio-Rad Laboratories Inc, Medical Equipment, Key Facts, 2017 2
Bio-Rad Laboratories Inc, Medical Equipment, Deals Summary, 2012 to YTD 2018 2
Bio-Rad Laboratories Inc, Medical Equipment, Deals By Year, 2012 to YTD 2018 6
Bio-Rad Laboratories Inc, Medical Equipment Deals By Type, 2012 to YTD 2018 7
Bio-Rad Laboratories Inc, Medical Equipment, Deals By Region, 2012 to YTD 2018 8
Bio-Rad Laboratories Inc, Deals By Market, 2012 to YTD 2018 9
Bio-Rad Laboratories Inc, Medical Equipment, Deals Summary, 2012 to YTD 2018 10
Bio-Rad Labs Acquires Flow Cytometer from Propel Labs 12
Bio-Rad Labs Acquires Cell Sorting System From Propel Labs 13
Oxford Impedance Diagnostics Raises USD2.6 Million in Seed Financing 14
RainDance Technologies Raises US$16.5 Million In Extended Series E Financing 15
RainDance Technologies Raises US$35 Million In Venture Financing 17
RainDance Technologies Raises US$20 Million In Series E Financing 18
AbD Serotec Enters Into Licensing Agreement With DiaSorin For HuCAL Antibodies 20
Bio-Rad Laboratories Enters into Partnership with Illumina 21
RainDance Technologies Enters into Research Agreement with Blood Systems Research Institute 22
Bio-Rad Labs Extends Agreement with Beckman Coulter Diagnostics 23
Bio-Rad Labs Enters Into Co-Development Agreement With Inpeco 24
Bio-Rad Labs Enters Into Co-Marketing Agreement With Lamprogen For Fluorescent Particles 25
RainDance Technologies Enters Into Co-Development Agreement With Integrated DNA Technologies For Digital PCR 26
Bio-Rad Labs Enters Into Distribution Agreement With Myriad RBM For Multiplex Biomarker Kits 27
Bio-Rad Labs Extends Distribution Agreement With Luminex For MAGPIX 28
GnuBIO Enters Into Co-Development Agreement With Montreal Heart Institute 29
Bio-Rad Labs Enters into Licensing agreement with Globavir Biosciences 30
RainDance Withdraws IPO for USD60 Million 31
Bio-Rad Labs Acquires RainDance Technologies 32
Bio-Rad Labs Completes Acquisition Of AbD Serotec From MorphoSys 33
Bio-Rad Laboratories Inc, Key Competitors 34
Bio-Rad Laboratories Inc, Key Employees 35
Bio-Rad Laboratories Inc, Subsidiaries 36

List of Figures
Bio-Rad Laboratories Inc, Medical Equipment, Deals by Type, 2012 to YTD 2018 2
Bio-Rad Laboratories Inc, Medical Equipment, Deals By Year, 2012 to YTD 2018 2
Bio-Rad Laboratories Inc, Medical Equipment, Deals By Region, 2012 to YTD 2018 2
Bio-Rad Laboratories Inc, Medical Equipment, Deals By Market, 2012 to YTD 2018 2
Bio-Rad Laboratories Inc, Medical Equipment, Deals By Year, 2012 to YTD 2018 6
Bio-Rad Laboratories Inc, Medical Equipment, Deals by Type, 2012 to YTD 2018 7
Bio-Rad Laboratories Inc, Medical Equipment, Deals By Region, 2012 to YTD 2018 8
Bio-Rad Laboratories Inc, Medical Equipment, Deals by Market, 2012 to YTD 2018 9

★海外企業調査レポート[Bio-Rad Laboratories Inc (BIO):医療機器:M&Aディール及び事業提携情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Inovio Pharmaceuticals Inc (INO):企業の財務・戦略的SWOT分析
    Inovio Pharmaceuticals Inc (INO) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and wea …
  • AxoGen Inc (AXGN)-医療機器分野:企業M&A・提携分析
    Summary AxoGen Inc (AxoGen), formerly LecTec Corp is a provider of surgical solutions for peripheral nerve injuries. The company offers AxoTouch two-point discriminator, AxoGuard nerve connector, Avance nerve graft, AcroVal NSTMS and AxoGuard nerve protector products. It also offers clinical researc …
  • Sally Beauty Holdings, Inc.:企業の戦略・SWOT・財務情報
    Sally Beauty Holdings, Inc. - Strategy, SWOT and Corporate Finance Report Summary Sally Beauty Holdings, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and ser …
  • Nissin Foods Holdings Co Ltd (2897):企業の財務・戦略的SWOT分析
    Nissin Foods Holdings Co Ltd (2897) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and …
  • RentPath LLC:企業の戦略的SWOT分析
    RentPath LLC - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services. …
  • Robert Half International Inc. (RHI):企業の財務・戦略的SWOT分析
    Robert Half International Inc. (RHI) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and …
  • Highmark Inc:企業の戦略的SWOT分析
    Highmark Inc - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services. …
  • Seadrill Ltd (SDRL):企業の財務・戦略的SWOT分析
    Seadrill Ltd (SDRL) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and t …
  • Tower Resources Ltd Oil & Gas Exploration and Production Operations and Cost Analysis – 2017
    Tower Resources Ltd Oil & Gas Exploration and Production Operations and Cost Analysis - 2017 Summary Tower Resources Ltd (Tower Resources), formerly Tower Energy Ltd is a junior mineral exploration company. The company operates in the business of mining, discovering and developing of economic minera …
  • SmartCool Systems Inc (SSC):電力:M&Aディール及び事業提携情報
    Summary SmartCool Systems Inc (SmartCool Systems) is a clean technology company that manufactures and sells energy and cost reduction technologies. The company’s products include ECO3, ESM, and soft solutions. Its ECO3 and ESM are retrofit technologies that reduce the energy consumption of compresso …
  • Biomerica Inc (BMRA):企業の製品パイプライン分析
    Summary Biomerica, Inc. (Biomerica) develops, manufactures, and markets medical diagnostic products used for the early detection and monitoring of chronic diseases and medical conditions. The company’s diagnostic test kits used to analyze blood, urine and fecal specimens of the patient to diagnose v …
  • OpGen Inc (OPGN)-製薬・医療分野:企業M&A・提携分析
    Summary OpGen Inc (OpGen) is a molecular diagnostics company that harnesses genomic analysis and bioinformatics to prevent the threat of antibiotic resistance and multi drug resistant organisms (MDROs). The company’s clinical laboratory services include high resolution microbial sequence analysis, s …
  • MicroStrategy Inc (MSTR):企業の財務・戦略的SWOT分析
    MicroStrategy Inc (MSTR) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses …
  • Hanger, Inc. (HNGR)
    Hanger, Inc. (HNGR) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company
  • STMicroelectronics N.V. (STM)-医療機器分野:企業M&A・提携分析
    Summary STMicroelectronics N.V. (ST) is a microelectronics company that designs, develops, manufactures, and markets a broad range of products for analog, digital, and mixed-signal applications. It offers standard commodity components, custom devices and semi-custom devices, application-specific int …
  • Mizuho Financial Group Inc:企業の戦略・SWOT・財務分析
    Mizuho Financial Group Inc - Strategy, SWOT and Corporate Finance Report Summary Mizuho Financial Group Inc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and servi …
  • Ceapro Inc (CZO)-製薬・医療分野:企業M&A・提携分析
    Summary Ceapro Inc (Ceapro) is a biotechnology company which focuses on the development of extraction technology for use in the production of extracts and active ingredients from oats and other renewable plant resources. These extracts find application in therapeutic products for both humans and ani …
  • TAT Technologies, Ltd.:企業の戦略・SWOT・財務分析
    TAT Technologies, Ltd. - Strategy, SWOT and Corporate Finance Report Summary TAT Technologies, Ltd. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offer …
  • Catalyst Biosciences Inc (CBIO)-医療機器分野:企業M&A・提携分析
    Summary Catalyst Biosciences Inc (Catalyst), formerly Targacept Inc is a clinical-stage biopharmaceutical company that develops novel medicines to address hematology indications. The company discovers and develops next generation biopharmaceuticals based on engineered human proteases platform techno …
  • Delaware North Companies Inc:企業の戦略的SWOT分析
    Delaware North Companies Inc - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major produc …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆